Showing 1 of 1 recruiting trials for “Mixed phenotype acute leukemia”
Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →